GlassScriptPhysician profile
Jeffry P Menzner
NPI 1487607198
$194,019.59
in general payments reported to CMS, 2019-2025
15 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $242 · 2021: $1,542 · 2022: $149 · 2023: $376 · 2024: $190K · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $190K · Food and Beverage: $1,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $189,670.05 |
| Food and Beverage | $1,759.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $189,976.16 | 2019-2025 | Arcos, Persona, Equivabone |
| Depuy Synthes Sales INC. | $2,527.20 | 2019-2025 | |
| Carbofix Orthopedics INC | $227.48 | 2023 | |
| Heron Therapeutics, INC. | $207.31 | 2022-2025 | Zynrelef |
| Stryker Corporation | $205.81 | 2019 | |
| Medical Device Business Services, INC. | $182.38 | 2021-2025 | Attune |
| Pacira Pharmaceuticals Incorporated | $143.75 | 2021-2024 | Exparel |
| Medtronic USA, INC. | $113.96 | 2019 | |
| Orthalign INC | $91.77 | 2024 | Orthalign Plus |
| Bone Support INC. | $87.36 | 2022 | |
| Microport Orthopedics INC | $84.60 | 2021 | |
| Davol INC. | $61.31 | 2020-2021 | |
| Sawtooth Surgical Solutions INC | $59.36 | 2025 | |
| Ethicon US, LLC | $36.56 | 2020 | |
| Solventum Corporation | $14.58 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffry Menzner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.